HK1145342A1 - Prognosis prediction for melanoma cancer - Google Patents
Prognosis prediction for melanoma cancerInfo
- Publication number
- HK1145342A1 HK1145342A1 HK10111778.3A HK10111778A HK1145342A1 HK 1145342 A1 HK1145342 A1 HK 1145342A1 HK 10111778 A HK10111778 A HK 10111778A HK 1145342 A1 HK1145342 A1 HK 1145342A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- markers
- cancer
- prognostic
- melanoma
- prognosis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ555363A NZ555363A (en) | 2007-05-24 | 2007-05-24 | Prognosis prediction for melanoma cancer |
PCT/NZ2008/000118 WO2008143533A1 (en) | 2007-05-24 | 2008-05-23 | Prognosis prediction for melanoma cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1145342A1 true HK1145342A1 (en) | 2011-04-15 |
Family
ID=40032133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10111778.3A HK1145342A1 (en) | 2007-05-24 | 2010-12-16 | Prognosis prediction for melanoma cancer |
Country Status (17)
Country | Link |
---|---|
US (3) | US8822149B2 (de) |
EP (2) | EP3176270B1 (de) |
JP (5) | JP5943315B2 (de) |
CN (1) | CN101743327B (de) |
AR (1) | AR066725A1 (de) |
AU (1) | AU2008253836B2 (de) |
CA (1) | CA2725602A1 (de) |
CL (1) | CL2008001517A1 (de) |
DK (2) | DK3176270T3 (de) |
ES (2) | ES2622858T3 (de) |
HK (1) | HK1145342A1 (de) |
NZ (1) | NZ555363A (de) |
PT (2) | PT3176270T (de) |
SG (2) | SG10201509568QA (de) |
TW (2) | TWI582236B (de) |
UY (1) | UY31105A1 (de) |
WO (1) | WO2008143533A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120135415A1 (en) * | 2002-11-15 | 2012-05-31 | Morehouse School Of Medicine | Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies |
US20100105571A1 (en) | 2007-03-27 | 2010-04-29 | Carl Arne Krister Borrebaeck | Protein Signature/Markers for the Detection of Adenocarcinoma |
JP5683280B2 (ja) * | 2011-01-04 | 2015-03-11 | 株式会社日立製作所 | 診療支援システム |
CN102617734B (zh) * | 2011-12-28 | 2013-09-04 | 暨南大学 | 抗FGF-2抗体Dab-2及其应用 |
US9336302B1 (en) | 2012-07-20 | 2016-05-10 | Zuci Realty Llc | Insight and algorithmic clustering for automated synthesis |
US9355105B2 (en) * | 2012-12-19 | 2016-05-31 | International Business Machines Corporation | Indexing of large scale patient set |
NZ712575A (en) | 2013-03-14 | 2019-08-30 | Castle Biosciences Inc | Methods for predicting risk of metastasis in cutaneous melanoma |
US10687711B2 (en) * | 2015-05-05 | 2020-06-23 | Medizinische Universität Wien | Computerized device and method for processing image data |
WO2018009887A1 (en) * | 2016-07-08 | 2018-01-11 | University Of Hawaii | Joint analysis of multiple high-dimensional data using sparse matrix approximations of rank-1 |
US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
US10692605B2 (en) | 2018-01-08 | 2020-06-23 | International Business Machines Corporation | Library screening for cancer probability |
TW202018727A (zh) | 2018-11-09 | 2020-05-16 | 財團法人工業技術研究院 | 整體式學習預測方法與系統 |
EP3935581A4 (de) | 2019-03-04 | 2022-11-30 | Iocurrents, Inc. | Datenkompression und -kommunikation mit maschinenlernung |
GB202010970D0 (en) | 2020-07-16 | 2020-09-02 | Immunovia Ab | Methods, arrays and uses thereof |
CN112200391B (zh) * | 2020-11-17 | 2023-07-04 | 国网陕西省电力公司经济技术研究院 | 基于k-近邻互信息特征简化的配电网边缘侧负荷预测方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0606228A2 (pt) | 2005-01-05 | 2009-06-09 | Abbott Lab | inibidores de enzima 11-beta-hidroxiesteróide desidrogenase tipo 1 |
AU2006203830A1 (en) * | 2005-01-07 | 2006-07-13 | The Johins Hopkins University | Biomarkers for melanoma |
WO2008031041A2 (en) * | 2006-09-07 | 2008-03-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
EP2083852B1 (de) * | 2006-10-04 | 2014-12-10 | Dana-Farber Cancer Institute, Inc. | Tumorimmunität |
-
2007
- 2007-05-24 NZ NZ555363A patent/NZ555363A/en unknown
-
2008
- 2008-05-23 DK DK16203301.3T patent/DK3176270T3/da active
- 2008-05-23 DK DK08766967.7T patent/DK2158332T3/en active
- 2008-05-23 PT PT162033013T patent/PT3176270T/pt unknown
- 2008-05-23 EP EP16203301.3A patent/EP3176270B1/de active Active
- 2008-05-23 CN CN2008800248635A patent/CN101743327B/zh not_active Expired - Fee Related
- 2008-05-23 SG SG10201509568QA patent/SG10201509568QA/en unknown
- 2008-05-23 TW TW097119301A patent/TWI582236B/zh not_active IP Right Cessation
- 2008-05-23 ES ES08766967.7T patent/ES2622858T3/es active Active
- 2008-05-23 ES ES16203301T patent/ES2821300T3/es active Active
- 2008-05-23 CL CL2008001517A patent/CL2008001517A1/es unknown
- 2008-05-23 PT PT87669677T patent/PT2158332T/pt unknown
- 2008-05-23 WO PCT/NZ2008/000118 patent/WO2008143533A1/en active Application Filing
- 2008-05-23 JP JP2010509293A patent/JP5943315B2/ja not_active Expired - Fee Related
- 2008-05-23 TW TW103127682A patent/TWI609967B/zh not_active IP Right Cessation
- 2008-05-23 EP EP08766967.7A patent/EP2158332B1/de active Active
- 2008-05-23 CA CA2725602A patent/CA2725602A1/en not_active Abandoned
- 2008-05-23 AU AU2008253836A patent/AU2008253836B2/en not_active Ceased
- 2008-05-23 SG SG10201912289SA patent/SG10201912289SA/en unknown
- 2008-05-26 UY UY31105A patent/UY31105A1/es active IP Right Grant
- 2008-05-26 AR ARP080102210A patent/AR066725A1/es active IP Right Grant
-
2009
- 2009-11-23 US US12/592,385 patent/US8822149B2/en active Active
-
2010
- 2010-12-16 HK HK10111778.3A patent/HK1145342A1/xx not_active IP Right Cessation
-
2014
- 2014-08-29 US US14/472,755 patent/US9534258B2/en active Active
- 2014-10-31 JP JP2014223331A patent/JP2015061528A/ja active Pending
-
2016
- 2016-12-14 JP JP2016242254A patent/JP6404304B2/ja not_active Expired - Fee Related
- 2016-12-27 US US15/391,293 patent/US10266902B2/en not_active Expired - Fee Related
-
2018
- 2018-09-12 JP JP2018170779A patent/JP2019004907A/ja active Pending
-
2020
- 2020-06-04 JP JP2020097666A patent/JP2020150949A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1145342A1 (en) | Prognosis prediction for melanoma cancer | |
AU2016204376A1 (en) | MicroRNA-based methods and compositions for the diagnosis and treatment of ovarian cancer | |
NL301145I2 (nl) | Tirbanibulin | |
WO2007081720A3 (en) | Microrna-based methods and compositions for the diagnosis, prognosis and treatment of lung cancer | |
MX2009010439A (es) | Variantes geneticas de chr2 y chr16 como marcadores para el uso en valoracion, diagnosis, prognosis y tratamiento de riesgo de cancer de mama. | |
WO2007081740A3 (en) | Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers | |
WO2008104543A3 (en) | Method for predicting the occurrence of metastasis in breast cancer patients | |
MX341734B (es) | Biomarcadores para la prediccion de la eficacia de una inmunoterapia contra el cancer. | |
HK1108284A1 (en) | Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer | |
WO2008008430A3 (en) | Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases | |
MX2013002084A (es) | Biomarcadores y metodos de tratamiento. | |
EA201270553A1 (ru) | Ингибиторы тирозинкиназы брутона | |
EA201171367A1 (ru) | Винилиндазолильные соединения | |
NO20083397L (no) | Anti-EphB4-antistoffer og fremgangsmater for anvendelse av disse | |
WO2008030986A3 (en) | Molecular diagnosis and classification of malignant melanoma | |
MX2009005058A (es) | Metodos para tratar, diagnosticar o detectar cancer. | |
WO2009092108A3 (en) | Biomarkers for the diagnosis and treatment of pancreatic cancer | |
EA200971068A1 (ru) | Триазолиламинопиримидиновые соединения | |
MX2015000008A (es) | Uso de marcadores en el diagnostico y tratamiento de cancer de prostata. | |
TNSN08401A1 (en) | Methods of treating diagnosing or detecting cancer | |
TW200738751A (en) | Anti-EphrinB2 antibodies and methods using same | |
IN2012DN01979A (de) | ||
ATE525484T1 (de) | Slco1b3-genotyp | |
EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
WO2009089102A3 (en) | Identification and characterization of pregnancy- associated genetic signatures and use thereof for diagnosis and treatment of breast cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20210525 |